Advertisement
Proceeds from the financing will be used to fund the licensing anddevelopment of a novel drug being tested as a therapeutic to treat Alzheimer'sdisease. Sonexa has licensed worldwide, exclusive rights (except for Japan andcertain Asian countries) to the compound from a Japanese pharmaceuticalcompany. Human trials in the US are scheduled to begin February '08.
Advertisement
About Domain Associates
Founded in 1985, Domain Associates, L.L.C. is a venture capital firm withan exclusive focus on life sciences. With $2.1 billion of capital undermanagement, Domain is headquartered in Princeton, NJ with a second office inSan Diego, CA. Domain's three major investment segments are pharmaceuticals,specialty pharmaceuticals, and medical devices, while additional areas ofinterest include biomaterials, bioinstrumentation, and diagnostics. ThePartners of Domain have a total of close to 200 person-years of experienceamong them in the healthcare/venture capital industries and have been involvedin the formation and growth of more than 190 life-sciences companies. Formore information, visit http://www.domainvc.com.
About Scale Venture Partners
Based in Foster City, California, the ScaleVP team is a long-standingpartnership with a consistent, top quartile track record of returns. ScaleVenture Partners' insight-driven investment strategy, extensive operatingnetworks and go-to-market expertise help identify and build winning portfoliocompanies in technology and healthcare markets. The ScaleVP team's provenskill-set and active approach provides entrepreneurs a competitive advantagefor growth and category leadership. Representative portfolio companies includeAlimera Sciences, Discera, Frontbridge, Glu Mobile, mBlox, Monolithic PowerSystems, National Healing, NComputing, Omniture, Orexigen, ScanSafe, Somaxon,Vantage Media, Waterfront Media, Xceive and Zogenix. For more information,visit http://www.scalevp.com.
About Alta Partners
Alta Partners is a San Francisco based venture capital firm focused onlife sciences investing. Founded in 1996, the firm currently manages over $2billion in committed capital through eight venture fund programs. Altainvests in life sciences companies across the development continuum, fromcompany formation to later-stage venture opportunities, and has funded over110 companies in the sector to date. For more information, please visithttp://www.altapartners.com.Media Contact: For Sonexa: Eckard Weber, MD CEO Sonexa Therapeutics, Inc. [email protected] 858-480-2400 For Scale Venture Partners: Carol Sacks Tenor Communications [email protected] 650.520.8261
SOURCE Sonexa Therapeutics, Inc.
